EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CRISPRepi: a multi-omic atlas for CRISPR-based epigenome editing

Leisheng Shi, Shasha Li, Rongyi Zhu, Chenyang Lu, Xintian Xu, Changzhi Li, Xinyue Huang, Xiaolu Zhao, Fengbiao Mao iD, Kailong Li

Nucleic Acids Research · 06.01.2025 · 53 (D1) · D901-D913

DOI: 10.1093/nar/gkae1039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 12.11.2024. Verfasst von Leisheng Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, 100191, China. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Epigenome. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR-based epigenome editing integrates the precision of CRISPR with the capability of epigenetic mark rewriting, offering a tunable and reversible gene regulation strategy without altering the DNA sequences. Various epigenome editing systems have been developed and applied in different organisms and cell types; however, the detailed information is discrete, making it challenging to evaluate the precision of different editing systems and design the optimal sgRNAs for further functional studies. Herein, we developed CRISPRepi (http://crisprepi.maolab.org/ or http://crisprepi.lilab-pkuhsc.org/), a pioneering platform that consolidates extensive sequencing data from 671 meticulously curated RNA-seq, ChIP-seq, Bisulfite-seq and ATAC-seq datasets in 87 cell types manipulated by 74 epigenome editing systems. In total, we have curated 5962 sgRNAs associated with 283 target genes from 2277 samples across six species. CRISPRepi incorporates tools for analyzing editing outcomes and assessing off-target effects by analyzing gene expression changes pre- and post-editing, along with the details of multi-omic epigenetic landscapes. Moreover, CRISPRepi supports the investigation of editing potentials for newly designed sgRNA sequences in a cell/tissue-specific context. By providing a user-friendly interface for searching and selecting optimal editing designs across multiple organisms, CRISPRepi serves as an integrated resource for researchers to evaluate editing efficiency and off-target effects among diverse CRISPR-based epigenome editing systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsEpigenomeHumansAnimalsEpigenesis, GeneticSoftwareRNA, Guide, CRISPR-Cas SystemsMiceEpigenomicsClustered Regularly Interspaced Short Palindromic RepeatsMultiomics

Substanzen

RNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, 100191, China.
  • Cancer Center, Peking University Third Hospital, Beijing, 100191, China.
  • Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
  • Department of Biochemistry and Molecular Biology, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science Center, Beijing,…
  • Division of Rheumatology, Department of Internal Medicine, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Biomedical Research Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Shenzhen, 518036, China.

ORCID-Profile: Fengbiao Mao

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Beijing Nova Program
  • Beijing Natural Science Foundation
  • Fundamental Research Funds for the Central Universities
  • Postdoctoral Fellowship Program of CPSF
  • Natural Science Foundation of Guangdong Province
  • Guangdong Provincial Enterprise Joint Fund

Zitieren

APA

Shi, L., Li, S., Zhu, R., Lu, C., Xu, X., Li, C., Huang, X., Zhao, X., Mao, F., & Li, K. (2025). CRISPRepi: a multi-omic atlas for CRISPR-based epigenome editing. Nucleic Acids Research, 53(D1), D901-D913. https://doi.org/10.1093/nar/gkae1039

Vancouver

Shi L, Li S, Zhu R, Lu C, Xu X, Li C, et al. CRISPRepi: a multi-omic atlas for CRISPR-based epigenome editing. Nucleic Acids Research. 2025;53(D1):D901-D913. doi:10.1093/nar/gkae1039

BibTeX
@article{Shi2025,
  author = {Shi, Leisheng and Li, Shasha and Zhu, Rongyi and Lu, Chenyang and Xu, Xintian and Li, Changzhi and Huang, Xinyue and Zhao, Xiaolu and Mao, Fengbiao and Li, Kailong},
  title = {CRISPRepi: a multi-omic atlas for CRISPR-based epigenome editing},
  journal = {Nucleic Acids Research},
  year = {2025},
  volume = {53},
  number = {D1},
  pages = {D901--D913},
  doi = {10.1093/nar/gkae1039}
}
Kostenlos starten →